Faruqi & Faruqi says it is investigating Embecta in securities class action
Faruqi & Faruqi says investors in Embecta Corp. may face an Aug. 17 deadline to seek lead-plaintiff status in a securities class action tied to the company’s guidance and results.
Faruqi & Faruqi, LLP says it is investigating Embecta Corp. and is reminding investors of an Aug. 17, 2026, deadline to seek lead-plaintiff status in a federal securities class action against the company.
The notice says the case concerns alleged false and misleading statements and omissions about Embecta’s guidance and financial results. It says the complaint names Embecta and certain officers and directors and alleges violations of federal securities laws.
Background
The notice says investors who bought or acquired Embecta securities between Nov. 25, 2025, and May 4, 2026, may be eligible to participate. It also says investors do not need to serve as lead plaintiff to share in any recovery if the case moves forward.
According to the notice, the claims center on the company’s second-quarter fiscal 2026 results and the guidance it issued before and after that report. The alert says Embecta described its pen needle business as “incredibly resolute” shortly before cutting fiscal 2026 guidance.
Embecta reported second-quarter fiscal 2026 results on May 5, 2026, the notice says. It says the company missed guidance, lowered fiscal-year 2026 guidance and reported revenue decline of more than 14%, compared with prior guidance for revenue that was flat to down 2%.
The notice says the weaker performance was largely tied to pen needle sales. It also says Embecta stock fell from $9.25 on May 4, 2026, to $3.90 on May 5, 2026, a one-day drop of more than 57.8%.
What the notice says
The PR Newswire alert says Faruqi & Faruqi is investigating potential claims against Embecta and provides contact information for partner Josh Wilson. It also gives the case website as www.faruqilaw.com/EMBC.
The notice says the complaint alleges Embecta and certain officers and directors made materially false and misleading statements and omissions, including claims that the company’s guidance was unattainable.
What happens next
The notice says investors who want to seek lead-plaintiff status must act by Aug. 17, 2026. It says the lead plaintiff is the court-appointed representative for the class.
The case was described in a PR Newswire investor alert published Aug. 15, 2026.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
View the Web StoryA visual, tap-through version of this reportThis is the AMP version of the article. Read the full article on Atlas Watchline.